5 results
10-K
2023 FY
EX-2.9
SKYE
Skye Bioscience Inc
Annual report
21 Mar 24
8:41pm
8-K
EX-2.1
SKYE
Skye Bioscience Inc
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-2.1
SKYE
Skye Bioscience Inc
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
SC 13D/A
EX-2
SKYE
Skye Bioscience Inc
28 Mar 17
Nemus Bioscience, Inc.
12:00am
8-K
EX-2.1
SKYE
Skye Bioscience Inc
17 Oct 14
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next